Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model

• Main Authors: Karolina Seborova (Author), Kamila Koucka (Author), Alzbeta Spalenkova (Author), Petr Holy (Author), Marie Ehrlichova (Author), Tomas Sychra (Author), Lei Chen (Author), Hersh Bendale (Author), Iwao Ojima (Author), Cristian Sandoval-Acuña (Author), Jaroslav Truksa (Author), Pavel Soucek (Author), Radka Vaclavikova (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Taxanes are widely used in the treatment of ovarian carcinomas. One of the main problems with conventional taxanes is the risk of development of multidrug resistance. New-generation synthetic experimental taxoids (Stony Brook Taxanes; SB-T) have shown promising effects against various resistant tumo...